Admission Date:  [**2138-12-16**]              Discharge Date:   [**2138-12-25**]  Date of Birth:  [**2062-3-23**]             Sex:   M  Service: MEDICINE  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 11839**] Chief Complaint: Shortness of Breath  Major Surgical or Invasive Procedure: none   History of Present Illness: 76 y/o M with metastatic NSCLC with brain metastasis s/p resection and WBRT who has received no systemic therapy due to poor performance status who presented with complaints of increased SOB.
The patient received Cefepime, Vanco and Levofloxacin in the ER due to concern for pneumonia.
Past Medical History: Metastatic NSCLC diagnosed [**9-/2138**] with mets to brain s/p resection and WBRT HTN Prostate CA s/p seed treatment and chemotherapy in [**2134**] with a urologist at [**Hospital3 **] GERD  ONCOLOGIC HISTORY: [**2138-10-6**] in the setting of acute confusion, the patient presents, found to have a large left frontal cystic lesion, associated edema, given Decadron and transferred to [**Hospital1 **].
Pertinent Results: [**2138-12-16**] 07:00PM   WBC-9.0 RBC-4.43* HGB-11.8* HCT-36.8* MCV-83 MCH-26.7* MCHC-32.2 RDW-16.3* [**2138-12-16**] 07:00PM   NEUTS-82.7* LYMPHS-11.9* MONOS-4.2 EOS-0.8 BASOS-0.4 [**2138-12-16**] 07:00PM   PT-13.7* PTT-29.5 INR(PT)-1.3* [**2138-12-16**] 07:00PM   GLUCOSE-212* UREA N-17 CREAT-0.7 SODIUM-127* POTASSIUM-5.6* CHLORIDE-87* TOTAL CO2-32 ANION GAP-14 [**2138-12-16**] 07:00PM   CALCIUM-9.7 PHOSPHATE-2.8 MAGNESIUM-1.9 [**2138-12-16**] 07:22PM   LACTATE-2.5* K+-5.7* [**2138-12-16**] 08:13PM URINE  BLOOD-TR NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG [**2138-12-16**] 09:59PM   LACTATE-1.1 [**2138-12-16**] 08:13PM URINE  RBC-3* WBC-5 BACTERIA-NONE YEAST-NONE EPI-0 .
Brief Hospital Course: 76 y/o male (Haitan creole only speaking) nursing home patient oriented only to his name at baseline admitted with hypoxemia and hemoptysis due to progression of his primary NSCLC with concomittant progression of brain metastases.
His initial brain metastatsis was treated with neurosurgical resection in [**2138-9-11**] followed by WBRT.
Following admission, he was treated with supplemental oxygen and started on levofloxicin.
He was evaluated by radiation oncology on hospital day one and began the first of five palliative radiation fractions to his lung to control hemoptysis(400 cGy per fraction for total dose of [**2127**] cGy).
He was treated with broadening of his antibiotis and made an overnight recovery consistant with mucous plugging.
He continued to have hemoptysis but did not require blood transfusions and respiratory status had stabilized.
Given his goals of care, he was treated symptomatically with O2 by nasal cannula and shovel mask.
Morphine 1-2 mg prn Q2H or more frequently if needed.
Metoprolol IV as tolerated.
Lasix 20 mg prn.
Scheduled Nebulizers and prn.
Pt stabilized and 72 hrs prior to d/c did not require IV morphine or IV lasix.
Pt started on scheduled oral metoprolol with good tolerance and better heart rate control.
Added po metoprolol as scheduled since this has relieved his episodes of tachycardia and his tachypnea and hypertension.
PRN IV metoprolol was also given.
# Progressive metastatic NSCLC: He was not a candidate for systemic therapy due to his poor performance status.
# Hemoptysis: Due to progression of primary lung cancer.He remained hemodynamically stable and was treated with palliative radiation.Pt may develop radiation esophagitis and will need supportive care ( pain meds, sucralfate, oncology magic mix) .
Began vancomycin and zosyn IV in the ICU and completed 7 days .Pt d/c with additional 4 days of flagyl.
# Brain metastases: Continued Keppra 750 mg [**Hospital1 **].No evidence of increased edeam on head CT this admission.
# Encephalopathy/Delirium: Baseline confusion due to his underlying neurologic compromise following his neurosurgery.
# Hyperglycemia: Continued on insulin sliding scale.
#Urinary incontinence: Pt had a foley cath placed during hospital stay for close monitoring of volume status when he was hemodynaomically unstable.Foley d/c priori to d/c .
- 1 Capsule(s) by mouth daily TAMSULOSIN -  (Prescribed by Other Provider) - 0.4 mg Capsule, Ext Release 24 hr - 1 Capsule(s) by mouth daily at bedtime TRAZODONE -  (Prescribed by Other Provider) - 50 mg Tablet - 0.5 (One half) Tablet(s) by mouth  as needed for insomnia  Medications - OTC ACETAMINOPHEN [TYLENOL] -  (Prescribed by Other Provider) - 325 mg Tablet - 2 Tablet(s) by mouth  as needed for every 6 hours pain or temp BISACODYL -  (Prescribed by Other Provider) - 5 mg Tablet, Delayed Release (E.C.)
- 2 Tablet(s) by mouth daily bedtime CHOLECALCIFEROL (VITAMIN D3) -  (Prescribed by Other Provider) - 400 unit Capsule - 2 Capsule(s) by mouth daily DOCUSATE SODIUM -  (Prescribed by Other Provider) - 100 mg Capsule - 1 Capsule(s) by mouth twice a day INSULIN REGULAR HUMAN -  (Prescribed by Other Provider) - Dosage uncertain MAGNESIUM HYDROXIDE [MILK OF MAGNESIA CONCENTRATED] - (Prescribed by Other Provider) - Dosage uncertain SENNOSIDES -  (Prescribed by Other Provider) - 8.6 mg Tablet - 1 Tablet(s) by mouth daily   Discharge Medications: 1. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q6H (every 6 hours) as needed for fever/pain.
2. bisacodyl 5 mg Tablet, Delayed Release (E.C.)
3. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day): hold for loose stools.
4. levetiracetam 500 mg Tablet Sig: 1.5 Tablets PO BID (2 times a day).
5. tamsulosin 0.4 mg Capsule, Ext Release 24 hr Sig: One (1) Capsule, Ext Release 24 hr PO HS (at bedtime).
6. insulin regular human 100 unit/mL Solution Sig: Two (2) Injection ASDIR (AS DIRECTED): per sliding scale.
7. oxycodone 5 mg Tablet Sig: Two (2) Tablet PO Q4H (every 4 hours) as needed for pain.
8. nystatin 100,000 unit/mL Suspension Sig: Five (5) ML PO QID (4 times a day) for 5 days.
9. omeprazole 20 mg Capsule, Delayed Release(E.C.)
10. metoprolol tartrate 25 mg Tablet Sig: One (1) Tablet PO three times a day.
11. ipratropium bromide 0.02 % Solution Sig: One (1)  Inhalation every six (6) hours.
12. albuterol sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: One (1)  Inhalation Q6H (every 6 hours) as needed for SOB.
13. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Flagyl 500 mg Tablet Sig: One (1) Tablet PO every eight (8) hours for 5 days.
Lasix 20 mg Tablet Sig: One (1) Tablet PO every twenty-four(24) hours as needed for weight gain above 3 pounds /increased edema/increased sob.
16. morphine 10 mg/5 mL Solution Sig: [**5-20**]  PO every six (6) hours as needed for pain/sob.
ZOFRAN ODT 4 mg Tablet, Rapid Dissolve Sig: [**1-12**] Tablet, Rapid Dissolves PO every eight (8) hours as needed for nausea.
18. sucralfate 100 mg/mL Suspension Sig: Ten (10) ml PO four times a day as needed for epigastric pain/esopgagitis.
Discharge Disposition: Extended Care  Facility: [**Location (un) 582**] of [**Location (un) 583**]  Discharge Diagnosis: Progressive metastatic lung cancer Shortness of breath Hypoxemia (low oxygen) Hemoptysis (coughing blood) Pneumonia Non sustained ventricular tachycardia Congestive heart failure Confusion Brain metastasis Bone metastasis Hypertension (high blood pressure) Heart burn   Discharge Condition: Mental Status: Confused - always.
He was  treated with oxygen, antibiotics and radiation therapy.
After discussions Mr [**Known lastname 90469**]  son and health care proxy, [**Name (NI) **], code status was changed to DNR/DNI.
These were treated with morphine and medication to slow your heart rate.
